Treatment
Therapy with antibiotics is usually not necessary for treat-ment of
upper respiratory tract infection caused by M.
pneumoniae. However, treatment with antibiotics may be helpfulfor
management of Mycoplasma pneumonia,
because it reduces duration of illness and also reduces the number of Mycoplasma in clinical specimen. It also
reduces the symptoms, enhances resolution of pneumonia, and facilitates
recovery from the disease. Pneumonia is usually a self-limiting disease and is
not life-threatening in most patients.
M. pneumoniae remains susceptible to tetracyclines and
eryth-romycin, because these antibiotics act on the mycoplasmas by inhibiting
synthesis of protein. Tetracycline has the additional advantage of also being
active against most other mycoplas-mas and chlamydiae, the common causes of
nongonococcal urethritis.
Mycoplasma organisms are resistant to penicillins and
cepha-losporins, because these antibiotics act on the cell wall, which is
lacking in mycoplasmas.
Prevention and Control
Isolation of the patients infected with M. pneumoniae is the best way to prevent the spread of the disease.
Antibiotic prophylaxis with tetracyclines or erythromycin is also useful. No vaccine
is available against Mycoplasma
infections.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.